Janux Therapeutics Inc.

25.53
-1.46 (-5.41%)
At close: Apr 04, 2025, 1:54 PM

Janux Therapeutics Revenue

Janux Therapeutics reported an annual revenue of $10.59M, reflecting a 30.99% growth. For the quarter ending December 31, 2024, Janux Therapeutics generated $0 in revenue.
Revenue (ttm)
$10.59M
Revenue Growth
30.99%
Price / Sales Ratio
271.8
Revenue / Employee
$130.72K
Employees
81
Market Cap
1.51B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 10.59M +30.99%
Dec 31, 2023 8.08M -6.14%
Dec 31, 2022 8.61M +136.79%
Dec 31, 2021 3.64M +Infinity%
Dec 31, 2020 0 n/a